The goal of this clinical trial is to investigate the local delivery of minocycline gel 2% and 0.2% hyaluronan gel to treat periodontitis in diabetic patients as adjunctive to subgingival instrumentation. The main question it aims to answer is: Does local use of minocycline gel and hyaluronan gel as an adjunct to SRP have resulted in significant additional improvement in the clinical conditions of stage II grade B periodontitis patients when compared with SRP alone?
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Probing pocket depth (PPD)
Timeframe: Probing pocket depth will be recorded at baseline and after 3 months post treatment from the gingival margines to the base of the pocket.
Clinical attachment loss (CAL)
Timeframe: Clinical attachment level will be recorded at baseline and 3 month post treatment.
Microbiological assessment
Timeframe: Porphyromonas gingivalis, Prevotella intermedia will be counted in subgingival plaque samples at baseline and after 3 months post-treatment